| 食管静脉曲张硬化剂治疗对门脉高压性胃病的影响 |
| |
| 引用本文： | 许小江. 食管静脉曲张硬化剂治疗对门脉高压性胃病的影响[J]. 河北医学, 2005, 11(5): 401-402 |
| |
| 作者姓名： | 许小江 |
| |
| 作者单位： | 广东医学院第二附属医院消化科,广东,湛江,524003 |
| |
| 摘 要： | 目的:探讨食管静脉曲张硬化剂治疗对门脉高压性胃病(PHG)的影响。方法:回顾性分析86例术后随访结果,并探讨其病因。结果:注射硬化剂前PHG14例,检出率16.3%。注射硬化剂后PHG发生率84.9%(73/86),明显升高,差异有显著性(P<0.05)。结论:食管静脉曲张硬化剂治疗明显增加和加重PHG。
|
| 关 键 词： | 食管静脉曲张 硬化剂治疗 门脉高压性胃病 |
| 文章编号： | 1006-6233(2005)05-0401-02 |
The Effects of Sclerotherapy for Esophageal Varices on Portal Hypertensive Gastropathy |
| |
| XU Xiao-jiang. The Effects of Sclerotherapy for Esophageal Varices on Portal Hypertensive Gastropathy[J]. Hebei Medicine, 2005, 11(5): 401-402 |
| |
| Authors: | XU Xiao-jiang |
| |
| Abstract: | Objective: To investigate the effects of sclerotherapy of esophageal varices (EV) on portal hypertensive gastropathy.Method: Retrospective analysis was performed over 86 follow-up results after operation and its cause was discussed. Results: Before injection the positive rate among 14 cases of PHG is 16.3%. After injection the occurrence rate of PHG is 84.9%(73/86) which was increased significantly. The difference is significance (p<0.05). Conclusion: Sclerotherapy for esophageal varices (EV) will significantly cause the development of PHG. |
| |
| Keywords: | Esophageal varices Sclerotherapy Portal hypertensive gastropathy |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
